Genprex (Nasdaq: $GNPX) is a clinical-stage gene therapy company focused on developing life-changing technologies for patients with cancer and diabetes.
Joined July 2016
- Tweets 1,303
- Following 505
- Followers 2,311
- Likes 262
891 Photos and videos
Jun 2
A few members from the Genprex team attended #ASCO2026 this week where our collaborators' abstract was published detailing positive clinical data from studies of predictive biomarkers in patients receiving Reqorsa® for the treatment of #lungcancer.
2
110
May 26
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting: ow.ly/mlEW50Z4bQs #ASCO #LungCancer
4
124
May 15
Our research collaborators presented positive preclinical data on our diabetes gene therapy at the 2026 ASGCT Annual Meeting. The poster can be reviewed in detail by clicking here: ow.ly/5to850Z0ee2 #Diabetes #Type2 #GeneTherapy
4
128
May 14
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting: ow.ly/uQlx50YZtGn #GeneTherapy #Diabetes
3
153
May 13
Genprex was featured in Cure's Member Spotlight series, where they highlight the groundbreaking work of the companies and individuals in Cure’s community. Check out the Q&A with Genprex's President and CEO here: ow.ly/ByIR50YZ0Ns #GeneTherapy #LungCancer #Diabetes
1
3
5
223
Apr 30
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer: ow.ly/irx250YSoy9 #GeneTherapy #LungCancer
1
5
285
Apr 28
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting: ow.ly/hizI50YR0Ly #Diabetes #GeneTherapy
1
5
252
Apr 24
Genprex collaborators presented preclinical data at #AACR26 in a poster, titled, "Restoring TUSC2 function boosts NK cell cytotoxicity and antitumor immunity in vivo and in vitro." To view the poster, click here: ow.ly/cPHL50YNAi3 #GeneTherapy $GNPX
5
4
315
Apr 23
$GNPX Collaborators presented preclinical data on Reqorsa Gene Therapy in EML4-ALK bearing NSCLC at #AARC26. Read the poster in more detail here: ow.ly/fIJb50YNAbS #LungCancer #GeneTherapy
5
245
Apr 22
$GNPX's Chief Medical Officer, Mark Berger, MD, poses with one of our collaborators at the #AACR26 conference. To view the poster, "TROP2 and PTEN Biomarkers May Predict Patient Response to Reqorsa® Gene Therapy" in more detail, click here: ow.ly/Z1ol50YNA2l #LungCancer
1
1
7
344
Apr 22
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting: ow.ly/eQgk50YNUgU #LungCancer #GeneTherapy
2
3
262
Apr 21
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy: genprex.com/2026/04/21/genpr… #lungcancer #tailoredtreatment #genetherapy
1
2
4
168
Apr 20
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting: ow.ly/10Nl50YMtk6 #AACR #LungCancer #GeneTherapy #Oncology
1
4
323
Mar 18
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting: ow.ly/8LV250YvMYV #lungcancer #genetherapy
2
1
6
617
Mar 10
Genprex to Participate at BIO Europe Spring 2026: ow.ly/UTGR50YrO03 #Oncology #Diabetes #GeneTherapy $GNPX
3
445
Feb 23
Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer: ow.ly/FYPo50Ykblt
1
6
761
Feb 10
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers: ow.ly/yaq250YccwB #genetherapy #lungcancer
3
10
685
Jan 9
Genprex recently announced positive preliminary preclinical data in Type 2 diabetes. Watch this video featuring Genprex's CEO and CMO discussing the new data and what it means: genprex.com/videos/ #genetherapy #diabetes #video $GNPX
1
1
7
763
Jan 7
Genprex Provides Clinical Update on Diabetes Gene Therapy Program: genprex.com/2026/01/07/genpr… #genetherapy #diabetes $GNPX
1
3
498
Jan 6
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies: genprex.com/2026/01/06/genpr… #genetherapy #diabetes $GNPX
1
4
464